Literature DB >> 9509669

Immunity to mycobacteria with emphasis on tuberculosis: implications for rational design of an effective tuberculosis vaccine.

S H Kaufmann1, P Andersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9509669     DOI: 10.1159/000058699

Source DB:  PubMed          Journal:  Chem Immunol        ISSN: 0079-6034


× No keyword cloud information.
  10 in total

1.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG).

Authors:  G Batoni; S Esin; M Pardini; D Bottai; S Senesi; H Wigzell; M Campa
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice.

Authors:  P Andersen; B Smedegaard
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.

Authors:  Giovanni Delogu; Amy Li; Charlene Repique; Frank Collins; Sheldon L Morris
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine.

Authors:  I S Leal; M Flórido; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

6.  DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

Authors:  G Delogu; A Howard; F M Collins; S L Morris
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.

Authors:  Ying Xu; Enzhuo Yang; Jianguang Wang; Rui Li; Guanghua Li; Guoyuan Liu; Na Song; Qi Huang; Cong Kong; Honghai Wang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

8.  Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Crystal Shanley; Erin E Smith; Gopinath Palanisamy; Baolin Wang; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2008-05-28

Review 9.  Th1/Th2 balance in infection.

Authors:  C Infante-Duarte; T Kamradt
Journal:  Springer Semin Immunopathol       Date:  1999

10.  Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth.

Authors:  Patricia L Semple; Marcia Watkins; Virginia Davids; Alan M Krensky; Willem A Hanekom; Gilla Kaplan; Stanley Ress
Journal:  Clin Dev Immunol       Date:  2010-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.